Asgard Therapeutics

@AsgardThx

Spin-off company from the Cell Reprogramming Lab at Lund University focusing on developing cancer immunotherapies based on cell fate reprogramming.

Vrijeme pridruživanja: prosinac 2018.

Tweetovi

Blokirali ste korisnika/cu @AsgardThx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AsgardThx

  1. 4. velj

    We are Asgard Therapeutics and we are developing the next leap forward in by converting cancer cells into antigen-presenting immune cells.

    Poništi
  2. proslijedio/la je Tweet
    24. sij

    Asgard Therapeutics on the go! Pitching in London to make TrojanDC a reality!

    Poništi
  3. proslijedio/la je Tweet
    10. pro 2019.

    Prestigious ERC grant for innovative immunotherapy research:

    Poništi
  4. proslijedio/la je Tweet
    10. pro 2019.

    Filipe Pereira tilldelas ERC Consolidator Grant om 21 miljoner! Han ska införliva två olika forskningsfält – cellulär omprogrammering & cancerimmunterapi – i ett unikt projekt:

    Poništi
  5. proslijedio/la je Tweet
    27. stu 2019.

    Well done Fábio!

    Poništi
  6. proslijedio/la je Tweet
    27. stu 2019.

    Fábio Rosa “pitching” at the NOME Annual Meeting & Startup Competition! Good luck!

    Poništi
  7. proslijedio/la je Tweet
    12. stu 2019.

    Congratulations to and to the CEO for the excellent representation 2019!

    Poništi
  8. proslijedio/la je Tweet
    20. stu 2019.
    Poništi
  9. proslijedio/la je Tweet
    12. stu 2019.

    We won! Audience choice award of the ! Thank you to everyone that voted 2019

    Poništi
  10. proslijedio/la je Tweet
    12. stu 2019.

    Very interesting Slam at full of amazing ! Congratulations to for winning the competition🎉👏 we enjoyed all presentations.

    Poništi
  11. proslijedio/la je Tweet
    8. stu 2019.
    Poništi
  12. proslijedio/la je Tweet
    1. stu 2019.

    Meet our participants 👏👏 , axiom insights GmbH, , GPN Vaccines Pty Ltd, , osteolabs GmbH, Pantherna Therapeutics GmbH, Sagitta Biotech, , TOLREMO therapeutics AG. See them pitch at 's next month!

    Poništi
  13. proslijedio/la je Tweet
    13. lis 2019.

    How important are tumor-associated neutrophils in cancer? Check out this review

    Poništi
  14. 12. ruj 2019.

    Finance and partnerships to build an ATMP“ NLSDays pre-event

    Poništi
  15. proslijedio/la je Tweet

    This Analysis article, published in , examines the extent of genetic heterogeneity within several types of untreated cancers.

    Poništi
  16. 27. kol 2019.

    Asgard’s CEO, , presents at the LSX NORDIC CONGRESS in Stockholm, Sweden, tomorrow August 28th 2019. Save the date!

    Poništi
  17. proslijedio/la je Tweet
    26. kol 2019.
    Poništi
  18. proslijedio/la je Tweet
    28. lip 2019.

    Andrew Plump from ⁦⁩ quoting Scott Gottlieb at . I would dare to rephrase: we are entering a new frontier in medical innovation with the ability to reprogram a patient’s deadly cancer cell to make the immune system attack it! ⁦

    Poništi
  19. proslijedio/la je Tweet
    16. kol 2019.

    Fabio defending TrojanDC in the Translational Fellowship in

    Poništi
  20. 19. kol 2019.

    Fábio Rosa just presented Asgard Therapeutics vision on next generation at University of Oxford as a 2019 EIT Health Translational fellow. via @@noticiasdecoimbra

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·